Fitting the pieces together: current research on the genetic basis of attention-deficit/hyperactivity disorder (ADHD)

Evangelia Stergiakouli, Anita Thapar, Evangelia Stergiakouli, Anita Thapar

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a highly disruptive childhood-onset disorder that often persists into adolescence and adulthood. Comorbidity with other problems, such as autism, dyslexia and conduct disorder (CD) is very common. Although little is known about the pathophysiology of ADHD, family, twin and adoption studies have shown that it is highly heritable. Whole genome linkage studies suggest there are no common susceptibility genes of moderate effect size. Most published research has been based on functional candidate gene studies. The most consistent evidence for association with ADHD relates to a dopamine D4 receptor (DRD4) gene variable number tandem repeat (VNTR), a dopamine D5 receptor (DRD5) gene microsatellite and a dopamine transporter (DAT1) gene VNTR. In addition, the catechol-O-methyltransferase (COMT) val158/108 met variant has been shown to increase risk for associated antisocial behavior. The first genome-wide association studies (GWAS) of ADHD have been completed and although larger studies are still required to detect common risk variants, novel risk pathways are being suggested for ADHD. Further research on the contribution of rare variants, larger genome-wide association and sequencing studies and ADHD phenotype refinement is now needed.

Keywords: attention-deficit/hyperactivity disorder (ADHD); gene-environment interplay; genetics; genome-wide association study (GWAS); molecular genetics.

References

    1. Faraone SV, Perlis RH, Doyle AE, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57(11):1313–1323.
    1. Goodman R, Stevenson J. A twin study of hyperactivity – II. The aetiological role of genes, family relationships and perinatal adversity. J Child Psychol Psychiatry. 1989;30(5):691–709.
    1. Cantwell DP. Genetics of hyperactivity. J Child Psychol Psychiatry. 1975;16(3):261–264.
    1. Sprich S, Biederman J, Crawford MH, Mundy E, Faraone SV. Adoptive and biological families of children and adolescents with ADHD. J Am Acad Child Adolesc Psychiatry. 2000;39(11):1432–1437.
    1. Levy F, Hay DA, McStephen M, Wood C, Waldman I. Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry. 1997;36(6):737–744.
    1. Thapar A, Holmes J, Poulton K, Harrington R. Genetic basis of attention deficit and hyperactivity. Br J Psychiatry. 1999 Feb;:174, 105–111.
    1. Mill J, Petronis A. Pre- and peri-natal environmental risks for attention-deficit hyperactivity disorder (ADHD): the potential role of epigenetic processes in mediating susceptibility. J Child Psychol Psychiatry. 2008;49(10):1020–1030.
    1. Thapar A, Langley K, Owen MJ, O’Donovan MC. Advances in genetic findings on attention deficit hyperactivity disorder. Psychol Med. 2007;37:1681–1692.
    1. Thapar A, Langley K, O’Donovan M, Owen M. Refining the attention deficit hyperactivity disorder phenotype for molecular genetic studies. Mol Psychiatry. 2006;11(8):714–720.
    1. McGough JJ. Adult Manifestations of Attention-Deficit/Hyperactivity Disorder. In: Sadock B, Sadock V, Rouiz P, editors. Kaplan and Sadock’s Comprehensive Textbook of Psychiatry. Vol. 2. Philadelphia: Wloters Kluwer; 2009.
    1. Stawicki JA, Nigg JT, von Eye A. Family psychiatric history evidence on the nosological relations of DSM-IV ADHD combined and inattentive subtypes: new data and meta-analysis. J Child Psychol Psychiatry. 2006;47(9):935–945.
    1. McLoughlin G, Ronald A, Kuntsi J, Asherson P, Plomin R. Genetic support for the dual nature of attention deficit hyperactivity disorder: substantial genetic overlap between the inattentive and hyperactive-impulsive components. J Abnorm Child Psychol. 2007;35(6):999–1008.
    1. Klein RG, Mannuzza S. Long-term outcome of hyperactive children: a review. J Am Acad Child Adolesc Psychiatry. 1991;30(3):383–387.
    1. Taylor E, Sonuga-Barke E. Disorders of attention and activity. In: Rutter M, Bishop DV, Pine D, et al., editors. Rutter’s Child and Adolescent Psychiatry. 5th ed. Malden: Wiley-Blackwell; 2008.
    1. Larsson H, Lichtenstein P, Larsson JO. Genetic contributions to the development of ADHD subtypes from childhood to adolescence. J Am Acad Child Adolesc Psychiatry. 2006;45(8):973–981.
    1. Franke B, Vasquez AA, Johansson S, et al. Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD. Neuropsychopharmacology. 2010;35(3):656–664.
    1. Costa e Silva JA. Autism, a brain developmental disorder: some new pathopysiologic and genetics findings. Metabolism. 2008 57 Oct;(Suppl 2):S40–S43.
    1. Cuffe SP, Moore CG, McKeown RE. Prevalence and correlates of ADHD symptoms in the national health interview survey. J Atten Disord. 2005;9(2):392–401.
    1. Reiersen AM, Constantino JN, Grimmer M, Martin NG, Todd RD. Evidence for shared genetic influences on self-reported ADHD and autistic symptoms in young adult Australian twins. Twin Res Hum Genet. 2008;11(6):579–585.
    1. Ronald A, Simonoff E, Kuntsi J, Asherson P, Plomin R. Evidence for overlapping genetic influences on autistic and ADHD behaviors in a community twin sample. J Child Psychol Psychiatry. 2008;49(5):535–542.
    1. Moffitt TE. Adolescence-limited and life-course-persistent antisocial behavior: a developmental taxonomy. Psychol Rev. 1993;100(4):674–701.
    1. Thapar A, Harrington R, McGuffin P. Examining the comorbidity of ADHD-related behaviors and conduct problems using a twin study design. Br J Psychiatry. 2001;179:224–229.
    1. Taylor E, Chadwick O, Heptinstall E, Danckaerts M. Hyperactivity and conduct problems as risk factors for adolescent development. J Am Acad Child Adolesc Psychiatry. 1996;35(9):1213–1226.
    1. Biederman J, Mick E, Faraone SV, et al. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry. 2002;159(1):36–42.
    1. Rhee SH, Waldman ID, Hay DA, Levy F. Sex differences in genetic and environmental influences on DSM-III-R attention-deficit/hyperactivity disorder. J Abnorm Psychol. 1999;108(1):24–41.
    1. Rutter M. Gene-environment interdependence. Dev Sci. 2007;10(1):12–18.
    1. Linnet KM, Dalsgaard S, Obel C, et al. Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. Am J Psychiatry. 2003;160(6):1028–1040.
    1. Thapar A, Rutter M. Do prenatal risk factors cause psychiatric disorder? Be wary of causal claims. Br J Psychiatry. 2009;195(2):100–101.
    1. Thapar A, Harold G, Rice F, Langley K, O’Donovan M. The contribution of gene-environment interaction to psychopathology. Dev Psychopathol. 2007;19(4):989–1004.
    1. Thapar A, Stergiakouli E. Genetic influences on the development of childhood psychiatric disorders. Psychiatry. 2008;7(7):277–281.
    1. Zhou K, Dempfle A, Arcos-Burgos M, et al. Meta-analysis of genome- wide linkage scans of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2008;147B(8):1392–1398.
    1. DiMaio S, Grizenko N, Joober R. Dopamine genes and attention-deficit hyperactivity disorder: a review. J Psychiatry Neurosci. 2003;28(1):27–38.
    1. Gainetdinov RR. Dopamine transporter mutant mice in experimental neuropharmacology. Naunyn Schmiedebergs Arch Pharmacol. 2008;377:4–6. 301–313.
    1. Spencer TJ, Biederman J, Madras BK, et al. In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter. Biol Psychiatry. 2005;57(11):1293–1300.
    1. Sharp SI, McQuillin A, Gurling HM. Genetics of attention-deficit hyperactivity disorder (ADHD) Neuropharmacology. 2009;57:7–8. 590–600.
    1. Gizer IR, Ficks C, Waldman ID. Candidate gene studies of ADHD: a meta-analytic review. Hum Genet. 2009;126(1):51–90.
    1. Faraone SV, Doyle AE, Mick E, Biederman J. Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry. 2001;158(7):1052–1057.
    1. Li D, Sham PC, Owen MJ, He L. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD) Hum Mol Genet. 2006;15(14):2276–2284.
    1. El-Faddagh M, Laucht M, Maras A, Vohringer L, Schmidt MH. Association of dopamine D4 receptor (DRD4) gene with attention-deficit/hyperactivity disorder (ADHD) in a high-risk community sample: a longitudinal study from birth to 11 years of age. J Neural Transm. 2004;111(7):883–889.
    1. Langley K, Fowler TA, Grady DL, et al. Molecular genetic contribution to the developmental course of attention-deficit hyperactivity disorder. Eur Child Adolesc Psychiatry. 2009;18(1):26–32.
    1. Shaw P, Gornick M, Lerch J, et al. Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2007;64(8):921–931.
    1. Li J, Wang Y, Zhou R, et al. Association between polymorphisms in serotonin transporter gene and attention deficit hyperactivity disorder in Chinese Han subjects. Am J Med Genet B Neuropsychiatr Genet. 2007;144(1):14–19.
    1. Lowe N, Kirley A, Hawi Z, et al. Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes. Am J Hum Genet. 2004;74(2):348–356.
    1. Maher BS, Marazita ML, Ferrell RE, Vanyukov MM. Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis. Psychiatr Genet. 2002;12(4):207–215.
    1. Purper-Ouakil D, Wohl M, Mouren MC, Verpillat P, Ades J, Gorwood P. Meta-analysis of family-based association studies between the dopamine transporter gene and attention deficit hyperactivity disorder. Psychiatr Genet. 2005;15(1):53–59.
    1. Yang B, Chan RC, Jing J, Li T, Sham P, Chen RY. A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3′-UTR of dopamine transporter gene and attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2007;144B(4):541–550.
    1. Brookes K, Xu X, Chen W, et al. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry. 2006;11(10):934–953.
    1. Kahn RS, Khoury J, Nichols WC, Lanphear BP. Role of dopamine transporter genotype and maternal prenatal smoking in childhood hyperactive-impulsive, inattentive, and oppositional behaviors. J Pediatr. 2003;143(1):104–110.
    1. Neuman RJ, Lobos E, Reich W, Henderson CA, Sun LW, Todd RD. Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype. Biol Psychiatry. 2007;61(12):1320–1328.
    1. Brookes KJ, Mill J, Guindalini C, et al. A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy. Arch Gen Psychiatry. 2006;63(1):74–81.
    1. Langley K, Turic D, Rice F, et al. Testing for gene x environment interaction effects in attention deficit hyperactivity disorder and associated antisocial behavior. Am J Med Genet B Neuropsychiatr Genet. 2008;147B(1):49–53.
    1. Laucht M, Skowronek MH, Becker K, et al. Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample. Arch Gen Psychiatry. 2007;64(5):585–590.
    1. Cheuk DK, Wong V. Meta-analysis of association between a catechol- O-methyltransferase gene polymorphism and attention deficit hyperactivity disorder. Behav Genet. 2006;36(5):651–659.
    1. Thapar A, Langley K, Fowler T, et al. Catechol O-methyltransferase gene variant and birth weight predict early-onset antisocial behavior in children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2005;62(11):1275–1278.
    1. Caspi A, Langley K, Milne B, et al. A replicated molecular genetic basis for subtyping antisocial behavior in children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2008;65(2):203–210.
    1. Monuteaux MC, Biederman J, Doyle AE, Mick E, Faraone SV. Genetic risk for conduct disorder symptom subtypes in an ADHD sample: specificity to aggressive symptoms. J Am Acad Child Adolesc Psychiatry. 2009;48(7):757–764.
    1. O’Donovan MC, Craddock N, Norton N, et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet. 2008;40(9):1053–1055.
    1. Shifman S, Johannesson M, Bronstein M, et al. Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet. 2008;4(2):e28.
    1. Sullivan PF, Lin D, Tzeng JY, et al. Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry. 2008;13(6):570–584.
    1. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145):661–678.
    1. Weiss LA. Autism genetics: emerging data from genome-wide copy- number and single nucleotide polymorphism scans. Expert Rev Mol Diagn. 2009;9(8):795–803.
    1. Franke B, Neale BM, Faraone SV. Genome-wide association studies in ADHD. Hum Genet. 2009;126(1):13–50.
    1. Neale BM, Lasky-Su J, Anney R, et al. Genome-wide association scan of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2008;147B(8):1337–1344.
    1. Zuo L, Kranzler HR, Luo X, Covault J, Gelernter J. CNR1 variation modulates risk for drug and alcohol dependence. Biol Psychiatry. 2007;62(6):616–626.
    1. Lasky-Su J, Neale BM, Franke B, et al. Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet B Neuropsychiatr Genet. 2008;147B(8):1345–1354.
    1. Uhl GR, Drgon T, Johnson C, et al. Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify „connectivity constellation“ and drug target genes with pleiotropic effects. Ann N Y Acad Sci. 2008;1141:318–381.
    1. Lesch KP, Timmesfeld N, Renner TJ, et al. Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm. 2008;115(11):1573–1585.
    1. Anney RJ, Lasky-Su J, O’Dushlaine C, et al. Conduct disorder and ADHD: evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study. Am J Med Genet B Neuropsychiatr Genet. 2008;147B(8):1369–1378.
    1. Sonuga-Barke EJ, Lasky-Su J, Neale BM, et al. Does parental expressed emotion moderate genetic effects in ADHD? An exploration using a genome wide association scan. Am J Med Genet B Neuropsychiatr Genet. 2008;147B(8):1359–1368.
    1. Scherer SW, Lee C, Birney E, et al. Challenges and standards in integrating surveys of structural variation. Nat Genet. 2007;39(7 Suppl):S7–S15.
    1. Sebat J, Lakshmi B, Malhotra D, et al. Strong association of de novo copy number mutations with autism. Science. 2007;316(5823):445–449.
    1. Elia J, Gai X, Xie HM, et al. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol Psychiatry. 2010;15:637–646.
    1. Lesch KP, Selch S, Renner TJ, et al. Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree. Mol Psychiatry. 2010 Mar 23; [Epub ahead of print]
    1. Karl T, Herzog H. Behavioral profiling of NPY in aggression and neuropsychiatric diseases. Peptides. 2007;28(2):326–333.
    1. Williams HJ, Owen MJ, O’Donovan MC. Schizophrenia genetics: new insights from new approaches. Br Med Bull. 2009;91:61–74.
    1. Mardis ER. The impact of next-generation sequencing technology on genetics. Trends Genet. 2008;24(3):133–141.
    1. Siva N. 1000 Genomes project. Nat Biotechnol. 2008;26(3):256.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅